Preoperative therapy with pazopanib in high-risk soft tissue sarcoma: a phase II window-of-opportunity study by the German Interdisciplinary Sarcoma Group (GISG-04/NOPASS)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: BMJ Open 2016;6:e009558
- Schlagwort
-
Infektion
Infektiologie
- Ereignis
-
Veröffentlichung
- (wo)
-
Frankfurt am Main
- (wer)
-
Univ.-Bibliothek Frankfurt am Main
- (wann)
-
2016
- Beteiligte Personen und Organisationen
- URN
-
urn:nbn:de:hebis:30:3-373937
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
29.12.2025, 06:59 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ronellenfitsch, Ulrich
- Dimitrakopoulou-Strauss, Antonia
- Jakob, Jens
- Kasper, Bernd
- Nowak, Kai
- Pilz, Lothar R.
- Attenberger, Ulrike
- Gaiser, Timo
- Egerer, Gerlinde
- Fröhling, Stefan
- Derigs, Hans-Günter
- Schwarzbach, Matthias
- Hohenberger, Peter
- Univ.-Bibliothek Frankfurt am Main
Entstanden
- 2016
Ähnliche Objekte (12)
Disease Response to Pazopanib in Follicular Dendritic Cell Sarcoma
Neoadjuvant pazopanib treatment in high-risk soft tissue sarcoma: a quantitative dynamic 18F-FDG PET/CT study of the German Interdisciplinary Sarcoma Group
Harnessing soft tissue sarcoma with low-dose pazopanib – a matter of blood levels
PD-L1 tumour expression is predictive of pazopanib response in soft tissue sarcoma
Secondary spontaneous pneumothorax in patients with sarcoma treated with Pazopanib, a case control study
Safety and efficacy of Pazopanib in advanced soft tissue sarcoma: PALETTE (EORTC 62072) subgroup analyses
Good and sustained response to pembrolizumab and pazopanib in advanced undifferentiated pleomorphic sarcoma: a case report
Systemic Therapy for Soft Tissue Sarcoma: Proposals for the Optimal Use of Pazopanib, Trabectedin, and Eribulin
Ueber Sarcoma mammae
Osteosarcoma (Osteogenic sarcoma)
Gastric Myeloid Sarcoma
Endometrial stromal sarcoma
Disease Response to Pazopanib in Follicular Dendritic Cell Sarcoma
Neoadjuvant pazopanib treatment in high-risk soft tissue sarcoma: a quantitative dynamic 18F-FDG PET/CT study of the German Interdisciplinary Sarcoma Group
Harnessing soft tissue sarcoma with low-dose pazopanib – a matter of blood levels
PD-L1 tumour expression is predictive of pazopanib response in soft tissue sarcoma
Secondary spontaneous pneumothorax in patients with sarcoma treated with Pazopanib, a case control study
Safety and efficacy of Pazopanib in advanced soft tissue sarcoma: PALETTE (EORTC 62072) subgroup analyses
Good and sustained response to pembrolizumab and pazopanib in advanced undifferentiated pleomorphic sarcoma: a case report
Systemic Therapy for Soft Tissue Sarcoma: Proposals for the Optimal Use of Pazopanib, Trabectedin, and Eribulin
Ueber Sarcoma mammae
Osteosarcoma (Osteogenic sarcoma)
Gastric Myeloid Sarcoma
Endometrial stromal sarcoma
Disease Response to Pazopanib in Follicular Dendritic Cell Sarcoma
Neoadjuvant pazopanib treatment in high-risk soft tissue sarcoma: a quantitative dynamic 18F-FDG PET/CT study of the German Interdisciplinary Sarcoma Group
Harnessing soft tissue sarcoma with low-dose pazopanib – a matter of blood levels
PD-L1 tumour expression is predictive of pazopanib response in soft tissue sarcoma
Secondary spontaneous pneumothorax in patients with sarcoma treated with Pazopanib, a case control study
Safety and efficacy of Pazopanib in advanced soft tissue sarcoma: PALETTE (EORTC 62072) subgroup analyses
Good and sustained response to pembrolizumab and pazopanib in advanced undifferentiated pleomorphic sarcoma: a case report
Systemic Therapy for Soft Tissue Sarcoma: Proposals for the Optimal Use of Pazopanib, Trabectedin, and Eribulin
Ueber Sarcoma mammae
Osteosarcoma (Osteogenic sarcoma)
Gastric Myeloid Sarcoma